Inebilizumab reduces gMG severity in Phase 3 trial: Top-line data
High levels of anti-acetylcholine receptor (AChR) antibodies — the most common self-reactive antibodies known to drive myasthenia gravis (MG) — in people with ocular MG are linked to greater odds of developing generalized MG, according to a recent study. People with ocular MG who had high anti-AChR antibody…